REQUEST A DEMO
Total
USD $0.00
Search more companies

Novoline Pharm SRL (Romania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Novoline Pharm SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Novoline Pharm SRL is based in Romania, with the head office in TULCEA. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Novoline Pharm SRL was incorporated on August 17, 2015. There are currently 62 (2022) people employed by Novoline Pharm SRL. From the latest financial highlights, Novoline Pharm SRL reported a net sales revenue increase of 7.84% in 2023. There was a total growth of 20.61% in Novoline Pharm SRL’s total assets over the same period. The enterprise’s net profit margin decreased by 1.42% in 2023.

Headquarters
Strada Isaccei Nr. 7
TULCEA; Tulcea; Postal Code: 820164

Contact Details: Purchase the Novoline Pharm SRL report to view the information.

Basic Information
Total Employees:
Purchase the Novoline Pharm SRL report to view the information.
Outstanding Shares:
Purchase the Novoline Pharm SRL report to view the information.
Registered Capital:
Purchase the Novoline Pharm SRL report to view the information.
Incorporation Date:
August 17, 2015
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Novoline Pharm SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
7.84%
Total operating revenue
7.85%
Operating profit (EBIT)
-40.86%
EBITDA
-37.58%
Net Profit (Loss) for the Period
-50.16%
Total assets
20.61%
Total equity
34.99%
Operating Profit Margin (ROS)
-1.42%
Net Profit Margin
-1.42%
Return on Equity (ROE)
-44.28%
Debt to Equity Ratio
33.8%
Quick Ratio
0.07%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?